NDC codes

FDA NDC Directory
Product NDC (as listed)70709-062Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70709-0062Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70709-062-3070709006230707090062303 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Feb 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Tascenso ODT
Generic name (nonproprietary)
fingolimod lauryl sulfate
Active ingredients
Fingolimod lauryl sulfate — .25 mg/1
Dosage form
Tablet, Orally disintegrating
Route
Oral
Labeler
Cycle Pharmaceuticals LtdNDC labeler code 70709
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 214962
Marketing start
Listing expires
Other FDA classes
Sphingosine 1-Phosphate Receptor Modulators (Mechanism)
Identifiers
Product ID 70709-062_fdba8834-a431-46b5-8dd2-5f57fb1efc79SPL ID fdba8834-a431-46b5-8dd2-5f57fb1efc79SPL set ID bf8e7f89-ea09-43c7-a7eb-e44724350721RxCUI 2610295, 2610302, 2626383, 2626385UNII J3HZQ9BE2SUPC 0370709062303
Pharmacologic class
Sphingosine 1-phosphate Receptor Modulator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470709006230 followed by a unit qualifier and the quantity

Package 70709-0062-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

TASCENSO ODT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. TASCENSO ODT is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70709-062

What is NDC 70709-062?
70709-062 is the product NDC for Tascenso ODT (fingolimod lauryl sulfate), Fingolimod lauryl sulfate .25 mg/1 tablet, orally disintegrating, listed with the FDA by Cycle Pharmaceuticals Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Tascenso ODT (Fingolimod Lauryl Sulfate).
What is the active ingredient?
Fingolimod lauryl sulfate.
Who is the labeler?
Cycle Pharmaceuticals Ltd, NDC labeler code 70709. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tascenso ODT?
1 other product NDC are listed under this name. See all Tascenso ODT NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tascenso ODT NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Tascenso ODTfingolimod lauryl sulfateFingolimod lauryl sulfate .5 mg/1Tablet, Orally disintegratingOralCycle Pharmaceuticals Ltd70709-06570709-0065-30

Other NDCs under NDA 214962

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 214962
ProductStrengthForm · routeLabelerProduct NDC
Tascenso ODTfingolimod lauryl sulfateFingolimod lauryl sulfate .5 mg/1Tablet, Orally disintegratingOralCycle Pharmaceuticals Ltd70709-065

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in